RARA and gastric cancer: In conclusion, the data obtained in HGC-27 cells with a pharmacological approach based on the use of RAR agonists and antagonists are consistent with the idea that activation of RARα is necessary and sufficient to mediate the anti-proliferative activity of ATRA in sensitive gastric-cancer cells.